Brief: Peptidream And Alnylam Announce Achievement Of Key Milestone In Sirna Conjugate Discovery Collaboration
18/12/2025 12:08
Dec 18 (Reuters) - PeptiDream Inc 4587.T: PEPTIDREAM AND ALNYLAM ANNOUNCE ACHIEVEMENT OF KEY MILESTONE IN SIRNA CONJUGATE DISCOVERY COLLABORATION DEMONSTRATING PEPTIDE-LIGAND MEDIATED TARGETED SIRNA DELIVERY TO SPECIFIC EXTRAHEPATIC TISSUES Source text: ID:nBw4ZS3wla Further company coverage: 4587.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner